Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) EBIT Margin (2023 - 2025)

Historic EBIT Margin for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to 263.76%.

  • Metagenomi's EBIT Margin fell 693600.0% to 263.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 298.48%, marking a year-over-year decrease of 1378500.0%. This contributed to the annual value of 170.0% for FY2024, which is 53800.0% up from last year.
  • As of Q3 2025, Metagenomi's EBIT Margin stood at 263.76%, which was down 693600.0% from 246.53% recorded in Q2 2025.
  • In the past 5 years, Metagenomi's EBIT Margin ranged from a high of 84.28% in Q2 2024 and a low of 674.1% during Q1 2025
  • For the 3-year period, Metagenomi's EBIT Margin averaged around 240.68%, with its median value being 207.21% (2023).
  • As far as peak fluctuations go, Metagenomi's EBIT Margin soared by 741600bps in 2024, and later plummeted by -4139300bps in 2025.
  • Quarter analysis of 3 years shows Metagenomi's EBIT Margin stood at 162.88% in 2023, then tumbled by -32bps to 214.51% in 2024, then dropped by -23bps to 263.76% in 2025.
  • Its EBIT Margin stands at 263.76% for Q3 2025, versus 246.53% for Q2 2025 and 674.1% for Q1 2025.